Loading

Annals of Pediatrics and Child Health

Mortality in Hospitalized Children Aged 1-59 Months with Pneumonia at Two Tertiary Hospitals in Harare, Zimbabwe

Research Article | Open Access | Volume 9 | Issue 1

  • 1. Makanda-Charambira PD1*
+ Show More - Show Less
Corresponding Authors
Makanda-Charambira PD, Child And Adolescent Health Unit, Faculty of Medicine and Health Sciences ,University of Zimbabwe P.O. Box A178, Avondale, Harare, Zimbabwe Tel: 263242 2791631.
ABSTRACT

Background: Pneumonia is among the leading causes of mortality in children, accounting for 13% of global under 5 mortality. Studies to determine factors contributing to mortality in childhood pneumonia can help optimize utilization of scarce resources for the most effective preventive and early management strategies in resource limited settings.

Methods: This hospital based analytical cross-sectional study was conducted between 1 April and 30 July 2017. Hospitalized children aged 1 month to 59 months with WHO defined pneumonia/severe pneumonia were enrolled. They were evaluated to ascertain demographic characteristics, clinical features and laboratory features within 24 hours of admission as related to hospital stay and mortality.

Results: A total of 309 children were enrolled. The median age was 3 months (IQR 2-10 months) with those aged 2-11 months constituting 61.1% (n=189). Hypoxia was noted in 210 (68.0%) children and clinical features associated with hypoxia on admission were chest wall in drawing (p<0.001), grunting (p <0.001) and lethargy (p <0.001). Median hospital stay was 5 days (IQR: 3-8). The median hospital stay increased significantly with decreasing age (p=0.01) and children with chest X-ray abnormalities on admission were four times more likely to have a prolonged stay in hospital compared to children with normal chest X-rays. Overall mortality rate was 14.2% (n=44) with 36% (n=15) of total deaths occurring within 24hrs of admission. Factors strongly associated with mortality were: severe pneumonia (p=0.001), lethargy (p=0.0001), HIV infection (p=0.0001), hypoxia (p=0.001), central cyanosis (p=<0.001), grunting (p=<0.001), chest wall in drawing (p=0.001) comorbidities (p=<0.0001) and severe malnutrition (p=<0.0001).

Conclusion: Pneumonia remains a major cause of mortality among hospitalized children in Zimbabwe. Presence of lethargy, hypoxia, HIV infection, comorbidities, severe malnutrition and signs of severe pneumonia such as grunting, cyanosis, head nodding and chest wall in drawing are associated with increased odds of dying.

KEYWORDS

• Pneumonia

• Mortality

• Hypoxia

• Infection

CITATION

Makanda-Charambira PD, Mujuru HA, Ndhlovu A, Timire C, Nathoo KJ. Mortality in Hospitalized Children Aged 1-59 Months with Pneumonia at Two Tertiary Hospitals in Harare, Zimbabwe. Ann Pediatr Child Health 2021; 9(1): 1221.

ABBREVIATIONS

WHO: World Health Organization; UNICEF: United Nations Children’s Emergency Fund; MCEE: Maternal And Child Epidemiology Estimation Group; MICS: Multi Cluster Indicator Survey; HIV: Human Immunodeficiency Virus; MTCT: Mother To Child Transmission; PMTCT: Prevention Of Mother To Child Transmission; AIDS: Acquired Immunodeficiency Syndrome; DNA PCR: DNA Polymerase Chain Reaction; PCV: Pneumococcal Conjugate Vaccine; DPT: Diphtheria Pertussis Tetanus; PJP: Pneumocystis Jirovecii Pneumonia; PCP: Pneumocystis Carinii Pneumonia; GINA: Global Initiative For Asthma; MUAC: Mid Upper Arm Circumference; Hb: Hemoglobin; DBS: Dried Blood Spot; MRCZ: Medical Research Council Of Zimbabwe; JREC: Joint Research Ethics Committee

INTRODUCTION

Pneumonia is among the leading causes of mortality in children globally and accounts for 13% of under 5 mortality [1]. It is an entirely preventable disease but kills more children than any other illness in the world [2], making it a major target to achieve the sustainable development goals 3(SDG 3), of reducing mortality. The number of children dying from pneumonia has decreased substantially over the past three decades. In 1990, more than two million children died from pneumonia; by 2017 this number had fallen to 809,000 globally [3]. Most of these deaths occurred in Sub Saharan Africa and South Asia. In 2017, 245 per 100 000 children under 5 years died from pneumonia in Zimbabwe [1].

Factors contributing to mortality from childhood pneumonia include young age [14], HIV infection [4,15], prematurity [5], malnutrition [6], and disease severity at presentation [7]. HIV infection is associated with increased mortality from pneumonia, infected children being at higher risk than unexposed or exposed but uninfected children [4,15]. HIV exposed uninfected children have a general greater risk of hospitalization in their first year of life compared to HIV unexposed children [12]. Antiretroviral therapy, however significantly reduces mortality from severe pneumonia [13].

Decline in mortality has been attributed to increased availability of vaccines and antibiotics as well as improvements in the major risk factors such as malnutrition, high air pollution and poor sanitation [3]. Immunization against S. pneumoniae, H. influenza type b and measles virus reduce the prevalence and mortality from pneumonia [8-11].

Since the last study in Zimbabwe on mortality from pneumonia in 1989, many programmatic interventions directly impacting pneumonia in children have been implemented in the health sector including introduction of H. influenza and pneumococcal vaccines, roll out of prevention of mother to child transmission of HIV and improved access to anti-retroviral therapy. The aim of this study was to describe the clinical characteristics and factors associated with mortality in children aged 1-59 months admitted to tertiary hospitals in Harare.

MATERIALS AND METHODS

The study was conducted in the pediatric medical wards of two tertiary hospitals in Harare, the capital city of Zimbabwe. Children aged between 1 and 59 months hospitalized with WHO defined pneumonia/severe pneumonia were enrolled. Children diagnosed with asthma based on the Global Initiative of Asthma (GINA) definition [16], and inter hospital transfer patients were excluded. Convenient sampling was done and only children admitted from Monday to Friday were enrolled into the study.

Patients were assessed in the emergency department by the attending doctor and managed according to the local treatment guidelines. Enrollment into the study was within 24 hours of admission. Demographic data, including maternal /caregiver characteristics were recorded. A complete clinical examination was done and details of the respiratory distress, nutritional status, and any signs of shock [17], were captured. Oxygen saturations were monitored by pulse oximetry throughout the admission as part of standard of care but only the oxygen saturation at baseline and discharge were recorded for the study. Dr Trust® finger pulse oximeter was used. Weight was measured using a Salter scale to the nearest 0.1kg. Length or height in children below or above 24months respectively was done using a stadiometer (UNICEF S0114540 Baby/infant/adult L-hgt measuring system/SET-2). Non dominant arm mid upper arm circumference (MUAC) was measured in all children above 6 months of age per WHO recommendations [17].

Mothers had a rapid HIV test performed on admission if there was no documented HIV test result done within the past 3 months as per to national guidelines. An appropriate HIV test was subsequently performed in the HIV exposed children. HIV exposed infants below 9 months of age had HIV DNA PCR performed if they did not have documented results performed within the previous 3 months according to national PMTCT program guidelines. HIV exposed infants between 9-18 months had a rapid HIV test done first and positive tests were confirmed with a HIV DNA PCR test. Children above 18 months or those who had stopped breastfeeding for > 6 weeks had rapid HIV antibody test as the diagnostic test. Chest x-rays were done at the discretion of the managing team and interpreted by a certified radiologist. Days of hospital stay were recorded on discharge with duration of >5days defined as prolonged hospital stay [5].

Data were captured using EpiData software versions 3.1 for entry and version 2.2.2.182 for analysis (EpiData Association, Odense, Denmark). Data cleaning was done to check for completeness and any inconsistencies. Continuous variables were summarized using means and standard deviation or medians and inter-quartile ranges as appropriate. Categorical data were summarized using proportions. Categorical variables were compared using chi-square test as measures of effect and presented as odds ratios with 95% confidence intervals. Level of significance was set at 5%.

Permission to conduct the study was obtained from Harare Central Hospital Ethics Committee (HCHEC 150217/ 07), Joint Research Ethics Committee (JREC) for the University of Zimbabwe Faculty of Medicine and Health Sciences (JREC/61/17) and the Medical Research Council of Zimbabwe.

RESULTS

A total of 568 children aged below 59 months were admitted with the diagnosis of pneumonia/severe pneumonia at the 2 tertiary hospitals during the study period 1st April to 30th July 2017. Of these 523(92.1%) were aged between 1 - 59 months and therefore eligible for the study. A total of 309 children were enrolled into the study, with 210 (68.0%) and 99 (32.0%) having severe pneumonia and pneumonia respectively based on WHO definitions.

The median age was 3 months (IQR; 2-10months) with males (59.5%) and children aged 2-11 months constituting the majority (Table 1).

Table 1: Demographic characteristics of children aged 1-59 months hospitalized with pneumonia/severe pneumonia at two tertiary hospitals in

Harare, Zimbabwe.

Child demographics

Total

Deceased

Alive

OR 95% CI

p-value

Age in months

n=309

n=44

n=265

 

<2

53

2 (3.8)

51 (96.2)

0.18 (0.02-0.88)

0.02

11-Feb

189

30 (15.9)

159 (84.1)

0.86 (0.40-1.99)

0.7

Dec-59

67

12 (17.9)

55 (82.3)

Reference

 

Gestational age at birth

 

Pre-term (<37 weeks)

20

1 (5.0)

19 (95.0)

0.32 (0.01-2.20)

0.49

Term (37 weeks+)

222

31 (14.0)

191 (86.0)

Reference

 

Birth weight

 

<2500g

53

10 (18.9)

43 (81.1)

1.53(0.62-3.43)

0.28

≥ 2500g

250

33 (13.2)

217 (86.8)

Reference

 

Area of residence

 

Urban

273

35(12.8)

238(87.2)

0.44(0.19-1.02)

0.05

Rural

36

9(25.0)

27(75.0)

Reference

 

Mother’s age in years

 

<19

12

2(16.7)

10(83.3)

Reference

0.84

≥19

292

42(14.4)

250(85.6)

0.84(0.18-3.97)

 

Mothers level of education

 

 

 

 

 

Secondary and above

263

35(13.3)

228(86.7)

0.53(0.24-1.21)

0.13

Primary and below

41

9(22.0)

32(78.0)

Reference

 

Of the 196 children below 6 months of age, 107 (54.6%), were on exclusive breastfeeding and 254 (87.6%), of all children aged less than 24 months were still being breastfed. Three hundred and eight children (99.7%), were tested for HIV or had a recorded HIV result. Of these, nineteen (6.1%), children were confirmed to be HIV infected and 33 (10.7 %), were exposed but uninfected (HEU), while the rest were unexposed. Only 6 (31.6%), of the 19 HIV infected children and 25 (75.6%), of the 33 HEU were on cotrimoxazole prophylaxis (Table 1). Immunization was incomplete for age in 63 (20.4%), children. Of these, 37 (58.7%) ,had missed one dose of PCV, 4 (6.3%), missed two doses and 3 (4.7%), missed all 3 doses. Under nutrition was found in 93 (30.1%), children with 55(59.1%), of them being severely malnourished. Co-morbid conditions recorded were meningitis (n=9), trisomy 21 (n=9), and cardiac disease (n=19). Diarrhea was present in 58 (18.8%) children (Table 2).

Table 2: Presenting history of children hospitalized with pneumonia.

Child history

Total

Deceased

Alive

OR 95% CI

p value

Cough duration

 

≥14 days

30

3 (11.1)

27(88.9)

0.79(0.15-2.81)

1

<14days

260

32 (12.3)

228 (87.7)

Reference

 

Comorbidities

 

Yes

37

13 (35.1)

24 (64.9)

4.21(1.95-9.11)

<0.0001

No

272

31 (11.4)

241 (88.6)

Reference

 

Diarrhoea

 

Yes

58

12(20.7)

46(79.3)

1.79(0.86-3.73)

0.12

No

251

32(12.7)

219(87.3)

Reference

 

Previous admission (pneumonia

 

Yes

49

5 (10.2)

44 (89.8)

0.64(0.24-1.73)

0.38

No

260

39 (15.0)

221 (85.0)

Reference

 

< 6mo exclusive breastfeeding

 

No

89

13 (14.6)

76 (85.4)

1.66(0.69-3.99)

0.25

Yes

107

10 (9.3)

97 (90.7)

Reference

 

<24mo still breastfeeding

 

No

36

10(27.8)

26(72.2)

2.58(1.14-2.82)

0.02

Yes

254

33(13.0)

221(87.0)

Reference

 

HIV status

 

HIV-infected

19

8 (42.1)

11 (57.9)

5.92(2.20-15.96)

0.0001

HIV-exposed uninfected

33

8 (24.2)

25 (75.8)

2.61(1.07-6.33)

0.03

HIV unexposed

256

28 (10.9)

228 (89.1)

Reference

 

Cotrimoxazole given

 

No

21

5 (23.8)

16 (76.2)

0.58(0.17-2.01)

0.39

Yes

31

10 (32.3)

21 (67.7)

Reference

 

Pre-referral antibiotics

 

Yes

140

15(10.7)

125(89.3)

0.58(0.30-1.13)

0.11

No

169

29(17.2)

140(82.8)

Reference

 

Immunization status

 

Not up to date

63

12(19.0)

51(81.0)

1.57(0.76-3.27)

0.22

Up to date

246

32(13.0)

214(87.0)

Reference

 

Signs of respiratory distress present on admission were grunting (n=169, 54.7%), lethargy (n=172, 55.7%), head nodding (n=127, 41.1%), and chest wall indrawing (n=141, 45.6%) (Table 3).

Table 3: Examination findings of children hospitalized with pneumonia.

Child presentation on examination

Total

Deceased

Alive

OR 95% CI

p-value

N=309

N=44

N=265

Grunting

 

Yes

169

37 (21.9)

132 (78.1)

5.33 (2.29-12.37)

<0.001**

No

140

7 (5.0)

133 (95.0)

Reference

 

Lethargy

 

Yes

172

42 (24.4)

130 (75.6)

21.81 (5.17-91.9)

<0.0001

No

137

2 (1.5)

135 (98.5)

Reference

 

Head nodding

 

Yes

127

27 (21.3)

100 (78.7)

2.62 (1.36-5.05)

0.003**

No

182

17 (9.3)

165 (90.7)

Reference

 

Chest wall indrawing

 

Yes

141

31 (30.0)

110 (70.0)

2.50 (1.19-5.46)

0.001**

No

168

13 (7.7)

115 (92.3)

Reference

 

Central cyanosis

 

Yes

83

22 (26.5)

61 (73.5)

3.34 (1.73-6.45)

<0.001**

No

226

22 (9.3)

204 (90.3)

Reference

 

Oxygen saturation at admission

 

<90%

210

34 (16.2)

176 (83.8)

8.60 (2.11-75.12)

0.001**

≥90%

91

2 (2.2)

89 (97.8)

Reference

 

Nutritional status

 

Severe malnutrition

55

18 (32.7)

37 (62.3)

5.05 (2.36-10.81)

<0.0001**

Moderate malnutrition

38

8 (21.1)

30 (78.9)

2.77 (1.09-7.04)

0.03**

Well nourished

182

16 (8.8)

166(91.2)

Reference

 

Fever

 

Yes

199

29(14.6)

170(85.4)

1.08(0.55-2.12)

0.82

No

110

15(13.6)

95(86.5)

Reference

 

Table 4: Factors associated with hypoxia in children hospitalized with pneumonia.

 

Total

Hypoxia (%)

Crude OR

p-value

OR

p-value

Comorbidities

 

 

 

 

 

 

Yes

36

33 (91.7)

5.47

0.002

4.14

0.03

No

265

177 (66.8)

ref

ref

 

 

Chest wall indrawing

 

 

 

 

 

 

Severe

138

122 (88.4)

6.5

<0.0001

3.64

<0.001

Non-severe

163

88 (54.0)

ref

ref

 

 

Lethargy

 

 

 

 

 

 

Yes

164

138 (84.1)

4.79

<0.0001

2.66

0.001

No

137

72 (52.6)

ref

ref

 

 

Grunting

 

 

 

 

 

 

Yes

161

134 (83.2)

4.18

<0.0001

2.59

0.001

No

140

76 (54.3)

ref

ref

 

 

Mean oxygen saturation on admission was of 83.19% (range 42% to 99%). Hypoxia, defined as saturation below 90% was noted in 210 (68.0%), children. There were eight children who were critically ill on admission with unrecordable saturations due to shock. Clinical features associated with hypoxia on admission were chest wall indrawing (p<0.0001), grunting (p <0.0001), and lethargy (p <0.0001), on univariate analysis. All these remained significant on multivariate analysis (Table 2). Fever and malnutrition were not associated with hypoxia on admission. Chest X-rays were performed in 119 (38.5%) children. Normal chest x-ray findings were reported in 30 (25.2%) children while other x-ray findings were unilobar infiltrates in 24 (20.2%), multilobe infiltrates in 59 (49.6%), pleural effusions in 6 (5.0%) children. No association was found between an abnormal chest X-ray and mortality (OR 3.07; CI 0.66-14.2).

The mean saturation on discharge was 93.75% (SD 3.69). A total of 23 (8.7%) children had saturation below 90% at discharge and the lowest was 78%. One patient did not have oxygen saturation measured at discharge.

Median hospital stay was 5 days (IQR: 3-8). Children admitted with chest wall indrawing and those with lethargy were about twice more likely to be admitted for more than five days compared to those without these clinical signs (Table 5).

Table 5: Factors associated with prolonged hospital stay in children hospitalized with pneumonia.

Clinical feature

Long stay

Short stay

OR 95% CI

p-value

( >5 days)

(≤ 5 days)

Grunting

 

Yes

124 (73.4)

45 (26.6)

1.06 (0.64-1.76)

0.89

No

101 (72.1)

39(27.9)

Reference

 

Chest wall indrawing

 

Severe

112 (79.4)

29 (20.6)

1.88 (1.12-3.16)

0.02

Non-severe

113 (69.3)

55 (32.7)

Reference

 

Head nodding

 

Yes

97 (76.4)

30 (23.6)

1.36 (0.81-2.29

0.24

No

128 (70.3)

50 (29.7)

Reference

 

Lethargy

 

Yes

137 (79.7)

35 (20.3)

2.18 (1.31-3.63)

0.003

No

88 (64.2)

49 (35.8)

Reference

 

CXR result

 

Abnormal X-ray

55 (93.2)

4 (6.8)

4.18 (1.12-15.7)

0.02

Normal CXR

23 (76.7)

7 (23.3)

Reference

 

The median hospital stay increased significantly with decreasing age (p=0.01). The median hospital stay decreased from 6 days (IQR: 4 - 7) among children aged under 3 months to 3.5 days (IQR: 2.0 - 6.3) among children above 3 months. Children with chest X-ray abnormalities on admission were four times more likely to have a prolonged stay in hospital when compared to children with a normal chest X-ray (Table 5).

The case fatality rate was 14.2% (n=44), with 36% (n=16), of total deaths occurring within 24hrs of admission. The rate was highest in the 12 to 59 months age group (17.9%), compared to 2 to 11 (15.9), and those 1-2 months (3.8%) (Table 1). Age between 1 and 2 months, lethargy, HIV infection, hypoxia, central cyanosis, grunting, severe malnutrition and comorbidities were significantly associated with mortality. Gender, fever, history of prematurity, birth weight and concurrent diarrhea were not associated with mortality.

Children diagnosed with severe pneumonia had 8.6 times the odds of dying compared to those with pneumonia (p 0.001), and those who presented with lethargy had almost 22 times the odds of dying compared to those without (p <0.0001). Children with central cyanosis on admission were 3.34 times likely to die (p <0.001) (Table 6).

Table 6: Association between full blood count and mortality in children hospitalized with pneumonia.

 

Total

Deceased

Alive

 

OR 95% CI

 

p-value

N=275

n=39

n=218

Haemoglobin (g/dl)

 

<2mo

Low Hb (<13.4)

11

1(0.9)

10(90.9)

3.60(0.21-62.8)

0.35

Normal Hb (13.4 – 19.8)

37

1(2.7)

36(97.3)

Reference

 

2-11mo

 

High Hb (>14.1)

2

0 (0) †

2 (100)

Not applicable

0.53

Low Hb (<9.4)

82

14 (17.1)

68 (82.9)

1.07 (0.48-2.42)

0.86

Normal Hb (9.4 – 14.1)

87

14 (16.1)

73 (83.9)

Reference

 

12-59mo

 

High Hb (>13.5)

3

0 (0)

3 (100) †

Not applicable

0.54

Low Hb (<11.3)

26

6 (23.1)

20 (76.9)

2.40 (0.53-10.8)

0.25

Normal Hb (11.3 – 13.5 )

27

3 (11.1)

24 (88.9)

Reference

 

White cell count (X 109 cells/l)

277

40

237

 

 

Leucocytosis (wcc ≥18.0)

69

17 (24.6)

52 (75.4)

3.06 (1.49-6.32)

0.002

Leucopoenia (wcc <6.0)

11

4 (36.4)

7 (63.6)

5.35 (1.44-19.97)

0.01

Normal (5.0-17.9)

197

19 (9.6)

178 (90.4)

Reference

 

Platelet count (x 109 /l)

275

39

236

 

 

Thrombocytosis (plt>451)

150

16 (10.7)

134 (89.3)

0.66 (0.32-1.37)

0.26

Thrombocytopenia (<150)

14

6 (42.9)

8 (57.1)

4.15 (1.28-13.47)

0.01

Normal (150-450)

111

17 (15.3)

94 (84.7)

Reference

 

Hb-hemoglobin, wcc-white cell count, plt- platelets,

HIV infected children admitted with pneumonia were almost six times more likely to die compared to HIV unexposed uninfected (p 0.0001). The odds of dying among children that were severely malnourished was about five times that of children who were well nourished (p <0.0001).

There was no association between exclusive breastfeeding and mortality in infants below 6 months (p 0.25). However, children below 24 months who were no longer being breastfed had twice the odds of dying compared to those who were still being breastfed (p 0.02).

Presence of leukocytosis or leukopenia increased the risk of mortality 3 and 5 times respectively compared to normal white cell count in these children, while the risk was about six times if urea levels were high (p<0.0001) and 4 times if there was thrombocytopenia (p 0.01). Abnormal serum sodium levels also increased risk of mortality (Table 7).

Table 7: Association between urea and electrolyte levels and mortality in children hospitalized with pneumonia.

 

Total

Deceased

Alive

 

OR 95% CI

 

p-value

n=261

n= 37

n=224

Sodium

 

High (≥146 mmol/l)

32

10 (31.2)

22 (68.8)

5.80 (2.27-14.81)

0.0001

Low (113-134mmol/l)

50

14 (28.0)

36 (72.0)

4.97 (2.15-11.5)

0.0001

normal (135-145mmol/l)

179

13 (7.3)

166 (92.7)

Reference

 

Urea

267

39

228

 

High (≥6.5 mmo/l)

34

14 (41.2)

20 (58.8)

6.13 (2.70-13.9)

<0.0001

Low (<6.5mmol/l)

28

4 (14.3)

24 (85.7)

1.46 (0.46-4.62)

0.51

Normal (1.8-6.4 mmol/l)

205

21 (10.2)

184 (89.8)

Reference

 

Creatinine

263*

39

224

 

Abnormal

46

4 (8.7)

42 (91.3)

0.50 (0.12-1.50)

0.26

Normal (18-150µmol/l)

217

35 (10.8)

182 (89.2)

Reference

 

DISCUSSION

Pneumonia remains a major cause of mortality in hospitalized children with a case fatality rate of 14.2 % in this study and an unacceptably high proportion dying within 24hrs. This was similar to the 15% case fatality rate documented almost 30 years ago by Nathoo et al in Zimbabwean under 5 children with pneumonia [4]. The finding of higher mortality in male children is in agreement with other studies conducted in Africa and other parts of the world [19,45,46].

The reported strong association between age less than 1 year and risk of mortality from pneumonia was not evident in this present study [4,19,20]. This could be due to possible inclusion of viral bronchiolitis by using WHO case definition of pneumonia. However the high case fatality rate in children above 12 months of age in our study could be due to the higher numbers of HIV infected and HIV exposed uninfected in this age group unlike in the previous study by Nathoo et al were most HIV infected children were under 12 months of age [4]. As in our study, HIV exposed uninfected children with pneumonia have been shown to be at increased risk of mortality compared to HIV unexposed [15,4].

Breastfeeding during the first 23 months of life has been shown to be a key intervention for reducing pneumonia morbidity and mortality [40]. In this study breastfeeding was protective in children aged less than 24 months. Numerous immunological components of breast milk protect against respiratory infections [21]. Previous studies have documented young maternal age, low maternal education as being associated with increased risk of death [22]. No maternal related factors were found to be related to mortality in our study possibly due to small sample analyzed Malnutrition [31-34], and other comorbidities’ [22,35] association with mortality in children with pneumonia are well documented Our study also supports earlier studies which identified head nodding, grunting, chest wall in drawing and cyanosis as clinical signs that predict mortality [22,23] while chest wall in drawing, grunting and lethargy were predictors of hypoxia in children with pneumonia [24-27]. Importantly, central cyanosis is insensitive for accurate detection of hypoxia, as it identifies between 9-42% of children with hypoxemia [28,29]. WHO recommends the use of pulse oximetry in all neonates and children with emergency or priority signs during triaging even at first level health centers [28], but these are usually not available. In our study 8.7% of those who had oxygen saturation measurement on discharge were hypoxic. Hypoxia on discharge has been associated with increased risk of death and readmission [30].

Electrolyte abnormalities such as hyponatremia have been associated with increased risk of mortality in children with pneumonia [36]. In our study both high and low sodium levels at admission were associated with almost 5 times risk of dying from pneumonia. The justification for routinely measuring electrolytes in children with pneumonia in low resource setting needs to be explored.

Although in our study anaemia did not emerge as a significant risk factor for mortality, other studies have reported otherwise [37,38]. This could be due to the small sample size of children with severe anaemia (Hb < 6g/dl) which increases mortality risk [39]. Our study also showed that abnormal leucocyte count (either high or low) is associated with increased risk of death. High leukocyte count is an indicator of severity of illness and therefore, may be associated with mortality [5]. Bone marrow function might be depressed in severe infections leading to leukopenia [40]. Platelets have an important role in antimicrobial host defenses [41]. Thrombocytopenia may develop due to severe infection, inflammation or depletion of coagulation factors and thus serves as an indicator of severity of the illness [41], and an outcome predictor in patients with severe community-acquired pneumonia. Consistent with previous studies, thrombocytopenia was associated with higher mortality in children with pneumonia [42-44].

LIMITATIONS

The study was conducted midweek which missed children who came over the weekend which might cause some bias. Although seasonal variation in pneumonia was missed since the study was not conducted over a whole year it sets precedence of future broader studies. Patients not examined soon after admission but rather within the first 24 hours of admission could have had a change in the clinical symptoms and signs after starting antibiotics and receiving oxygen therapy, however all efforts were made to examine patients in the shortest time soon after admission. ART use was not analyzed in children who were HIV infected. The degree to which anaemia contributed to the hypoxia was also not analyzed in this study. Hydration status was assessed and managed by the attending doctor but that information was not captured.

CONCLUSION

Case fatality among hospitalized children between 1 – 59 months with pneumonia remains unacceptably high. Presence of lethargy, hypoxia, HIV infection, comorbidities, severe malnutrition and signs of severe pneumonia such as grunting, cyanosis, head nodding and chest wall indrawing are associated with increased likelihood of dying. Children who are HIV exposed but uninfected have a higher likelihood of dying when compared to those who are not HIV exposed. Strategies aimed at preventing HIV infection in children should be strengthened as presence of HIV infection increased the likelihood of mortality.

Breastfeeding up to 2 years of age was associated with a reduced risk of mortality in children with pneumonia. Low-cost high impact initiatives like breastfeeding up to 2 years of age should continue being encouraged.

Children with pneumonia who have chest wall indrawing, grunting, lethargy and presence of comorbidities were likely to have low oxygen saturations. Pulse oximetry should be made available in the emergency department to allow measurement of oxygen saturation on admission since cyanosis is not sensitive in identifying children with hypoxia. Oxygen saturation should be measured on discharge to avoid discharge of hypoxic children at risk of later mortality.

ACKNOWLEDGEMENTS

The authors are grateful to Kelvin Charambira for assisting with statistical analysis, parents/caregivers and children who participated in the study.

REFERENCES
  1. Roser M, Ritchie H, Dadonaite B. Child and Infant Mortality. Our World in Data. 2013; 10: 18
  2. dpicampaigns. ‘Forgotten’ pneumonia epidemic kills more children than any other disease. United Nations Sustainable Development. 2020.
  3. Pneumonia — no child should die from a disease we can prevent. Our World in Data. 2020.
  4. Nathoo KJ, Nkrumah FK, Ndlovu D, Nhembe M, Pirie DJ, Kowo H. Acute lower respiratory tract infection in hospitalized children in Zimbabwe. Ann Trop Paediat. 1992; 13: 253-261.
  5. Tiewsoh K, Lodha R, Pandey RM, Broor S, Kalaivani M, Kabra SK. Factors determining the outcome of children hospitalized with severe pneumonia. BMC Pediatr. 2009; 9: 15.
  6. Rice AL, Sacco L, Hyder A, Black RE. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bulletin of the World Health Organization. 2000; 78: 1207-1221.
  7. Ramachandran P, Nedunchelian K, Vengatesan A, Suresh S. Risk factors for mortality in community-acquired pneumonia among children aged 1–59 months admitted in a referral hospital. Indian Pediatr. 2012; 49: 889-895.
  8. Bloch AB, Orenstein WA, Stetler HC, Wassilak SG, Amler RW, Bart KJ, et al. Health impact of measles vaccination in the United States. Pediatrics. 1985; 76: 524-532.
  9. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011; 2: e00309-310.
  10. Becker-Dreps S, Amaya E, Liu L, Moreno G, Rocha J, Briceño R, et al. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infectious Dis Journal. 2014; 33: 637-642.
  11. Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol. 2010; 39: i172-i185.
  12. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV- exposed uninfected infants are at increased risk for severe infections in the first year of life. J Tropical Pediatr. 2012; 58: 505-508.
  13. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series. 2016.
  14. Bokade CM, Madhura AD, Bagul AS, Thakre SB. Predictors of mortality in children due to severe and very severe pneumonia. Nigerian Med J. 2015; 56: 287.
  15. Theodoratou E, McAllister DA, Reed C, Adeloye DO, Rudan I, Muhe LM, et al. Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study. Lancet Infect Dis. 2014; 14: 1250-1258.
  16. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2016.
  17. WHO, UNICEF. WHO child growth standards and the identification of severe acute malnutrition in infants and children. A Joint Statement by the World Health Organization and the United Nations Children’s Fund. 2009.
  18. What is the mortality rate for children with bronchiolitis? 2020.
  19. Sehgal V, Sethi GR, Sachdev HPS, Satyanarayana L. Predictors of mortality in subjects hospitalized with acute lower respiratory tract infections. Indian Pediatr. 1997; 34: 213-219.
  20. Leowski J. [Mortality from acute respiratory infections in children under 5 years of age: global estimates]. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales. 1986; 39: 138-144.
  21. Lamberti LM, Zakarija-Grkovi? I, Fischer Walker CL, Theodoratou E, Nair H, Campbell H, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health. 2013; 13: S18.
  22. Sonego M, Pellegrin MC, Becker G, Lazzerini M. Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies. PLoS ONE. 2015; 10: e0116380.
  23. Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe pneumonia. Pediatr Infect Dis J. 1989; 8: 852-855.
  24. Laman M, Ripa P, Vince J, Tefuarani N. Can clinical signs predict hypoxaemia in Papua New Guinean children with moderate and severe pneumonia? Ann Trop Paediatr. 2005; 25: 23-27.
  25. Basnet S, Adhikari RK, Gurung CK. Hypoxemia in children with pneumonia and its clinical predictors. Indian J Pediatr. 2006; 73: 777- 781.
  26. Dyke T, Lewis D, Heegaard W, Manary M, Flew S, Rudeen K. Predicting Hypoxia in Children with Acute Lower Respiratory Infection: a Study in the Highlands of Papua New Guinea. J Trop Pediatr. 1995; 41: 196- 201.
  27. Usen S, Weber M, Mulholland K, Jaffar S, Oparaugo A, Omosigho C, et al. Clinical predictors of hypoxaemia in Gambian children with acute lower respiratory tract infection: prospective cohort study. BMJ. 1999; 318: 86-91.
  28. WHO | Oxygen therapy for children: a manual for health workers [Internet]. WHO. World Health Organization. 2020.
  29. Ayieko P, English M. In Children Aged 2–59 months with Pneumonia, Which Clinical Signs Best Predict Hypoxaemia? J Trop Pediatr. 2006; 52: 307-310.
  30. Instability on Hospital Discharge and the Risk of Adverse Outcomes in Patients With Pneumonia | Infectious Diseases | JAMA Internal Medicine | JAMA Network. 2020.
  31. Lazzerini M, Seward N, Lufesi N, Banda R, Sinyeka S, Masache G, et al. Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001–12: a retrospective observational study. The Lancet Global Health. 2016; 4: e57-68.
  32. Rice AL, Sacco L, Hyder A, Black RE. Malnutrition as an underlying cause of childhood deaths associated with infectious diseases in developing countries. Bulletin of the World Health Organization. 2000; 78: 1207-1221.
  33. Suwanjutha S, Ruangkanchanasetr S, Chantarojanasiri T, Hotrakitya S. Risk factors associated with morbidity and mortality of pneumonia in Thai children under 5 years. Southeast Asian J Tropical Med Public Health. 1994; 25: 60-66.
  34. Chisti MJ, Tebruegge M, La Vincente S, Graham SM, Duke T. Pneumonia in severely malnourished children in developing countries–mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health. 2009; 14: 1173-1189.
  35. Nascimento-Carvalho CMC, Rocha H, Santos-Jesus R, Benguigui Y. Childhood pneumonia: clinical aspects associated with hospitalization or death. Brazilian J Infectious Dis. 2002; 6: 22-28.
  36. Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Pediatr. 1992; 29: 735-740.
  37. Zhang Q, Guo Z, Bai Z, MacDonald NE. A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatr Pulmonol. 2013; 48: 390-397.
  38. Banajeh SM, al-Sunbali NN, al-Sanahani SH. Clinical characteristics and outcome of children aged under 5 years hospitalized with severe pneumonia in Yemen. Ann Trop Paediatr. 1997; 17: 321-326.
  39. Maganga ER. Pneumonia case fatality rate in children under-five :Understanding variations in district hospitals in Malawi. 2004.
  40. Leukocytosis and Leukopenia - Infectious Disease and Antimicrobial Agents. 2020.
  41. Fanny Vardon-Bounes. Platelets Are Critical Key Players in Sepsis. 2019.
  42. Mirsaeidi M, Peyrani P, Aliberti S, Filardo G, Bordon J, Blasi F, et al. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest. 2010; 137: 416-420.
  43. Dunaiceva J, Sabelnikovs O. Incidence and Predictive Value of Thrombocytopenia in Patients with Severe Community Acquired Pneumonia. Acta Chirurgica Latviensis. 2015; 15: 35-39.
  44. Chiu N-C, Chi H, Peng C-C, Chang H-Y, Huang DT-N, Chang L, et al. Retrospective study of prognostic factors in pediatric invasive pneumococcal disease. PeerJ. 2017; 5: e2941.
  45. Prevalence-of-pneumonia-and-factors-associated-among-children- 259-months-old-in-wondo-genet-district-sidama-zone-snnpr- ethiopia.pd.pdf. 2017.
  46. Bekele F, Sinaga M, Quadri JA, Kumar A, Shariff A, Malik T. Factors associated with outcomes of severe pneumonia in children aged 2 months to 59 months at jimma university specialized hospital, southwest Ethiopia. Curr Pediatr Res. 2017.

Makanda-Charambira PD, Mujuru HA, Ndhlovu A, Timire C, Nathoo KJ. Mortality in Hospitalized Children Aged 1-59 Months with Pneumonia at Two Tertiary Hospitals in Harare, Zimbabwe. Ann Pediatr Child Health 2021; 9(1): 1221.

Received : 24 Dec 2020
Accepted : 21 Jan 2021
Published : 23 Jan 2021
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X